Ratings by Stifel (Derek Archilia)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/20/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2022 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2022 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2021 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2021 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2021 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2020 | Aimmune Therapeutics | AIMT | Maintain | Hold (N/A) |
|
Details | ||
| 5/26/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2020 | Argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2020 | Aimmune Therapeutics | AIMT | Maintain | Hold (N/A) |
|
Details | ||
| 5/8/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Hold (N/A) |
|
Details | ||
| 3/17/2020 | DBV Technologies S.A | DBVT | Downgrade | Hold (Buy) |
5.26 (0.69) |
-86.88% | Details | |
| 3/12/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2020 | Aimmune Therapeutics | AIMT | Maintain | Hold (N/A) |
|
Details | ||
| 2/24/2020 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Hold (N/A) |
|
Details | ||
| 2/14/2020 | Rhythm Pharmaceuticals | RYTM | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2020 | Aimmune Therapeutics | AIMT | Maintain | Hold (N/A) |
|
Details | ||
| 1/28/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2020 | Momenta Pharmaceuticals | MNTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2020 | DBV Technologies S.A | DBVT | Upgrade | Buy (Hold) |
11.24 (5.26) |
-53.2% | Details | |
| 12/9/2019 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2019 | Momenta Pharmaceuticals | MNTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2019 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2019 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2019 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2019 | Aimmune Therapeutics | AIMT | Maintain | Hold (N/A) |
|
Details | ||
| 8/19/2019 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2019 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | AnaptysBio | ANAB | Maintain | Hold (N/A) |
|
Details | ||
| 7/12/2019 | Rhythm Pharmaceuticals | RYTM | Upgrade | Buy (Hold) |
21.75 (8.49) |
-60.97% | Details | |
| 6/21/2019 | AnaptysBio | ANAB | Downgrade | Hold (Buy) |
67.02 (24.10) |
-64.04% | Details | |
| 5/2/2019 | Pacira Pharmaceuticals | PCRX | Upgrade | Hold (Sell) |
46.25 (25.50) |
-44.86% | Details | |
| 5/1/2019 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2019 | AnaptysBio | ANAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Sell (N/A) |
|
Details | ||
| 2/4/2019 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2019 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2018 | DBV Technologies S.A | DBVT | Downgrade | Hold (Buy) |
14.69 (11.24) |
-23.49% | Details | |
| 12/10/2018 | Esperion Therapeutics | ESPR | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2018 | Rhythm Pharmaceuticals | RYTM | Maintain | Hold (N/A) |
|
Details | ||
| 11/7/2018 | Momenta Pharmaceuticals | MNTA | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2018 | argenx SE | ARGX | Maintain | Buy (Buy) |
|
Details | ||
| 9/14/2018 | argenx SE | ARGX | New Coverage | Buy (N/A) |
89.10 (368.60) |
313.69% | Details | |
| 9/14/2018 | DBV Technologies S.A | DBVT | New Coverage | Buy (N/A) |
23.20 (14.69) |
-36.68% | Details | |
| 9/14/2018 | Aimmune Therapeutics | AIMT | New Coverage | Hold (N/A) |
29.07 (34.49) |
18.64% | Details | |
| 9/14/2018 | Momenta Pharmaceuticals | MNTA | New Coverage | Buy (N/A) |
28.40 (52.48) |
84.79% | Details | |
| 9/14/2018 | Heron Therapeutics | HRTX | New Coverage | Buy (N/A) |
34.95 (2.55) |
-92.7% | Details | |
| 9/14/2018 | Pacira Pharmaceuticals | PCRX | New Coverage | Sell (N/A) |
46.45 (46.25) |
-0.43% | Details | |
| 9/14/2018 | Vanda Pharmaceuticals | VNDA | New Coverage | Buy (N/A) |
18.45 (12.69) |
-31.22% | Details | |
| 9/14/2018 | Rhythm Pharmaceuticals | RYTM | New Coverage | Hold (N/A) |
30.77 (21.75) |
-29.31% | Details | |
| 9/14/2018 | UroGen Pharma | URGN | New Coverage | Buy (N/A) |
43.90 (13.82) |
-68.52% | Details | |
| 9/14/2018 | AnaptysBio | ANAB | New Coverage | Buy (N/A) |
85.31 (67.02) |
-21.44% | Details | |
| 9/14/2018 | Esperion Therapeutics | ESPR | New Coverage | Buy (N/A) |
46.95 (1.99) |
-95.76% | Details | |
| 9/13/2018 | Selecta Biosciences | SELB | New Coverage | Buy (N/A) |
14.05 (3.69) |
-73.74% | Details |
